Molecular analysis of sarcoglycanopathies in Russian LGMD patients

被引：0
|
作者：
Bulakh, M. V. [1 ]
Ryzhkova, O. P. [1 ]
Polyakov, A. V. [1 ]
机构：
[1] Res Ctr Med Genet, Fed State Budgetary Inst, Moscow, Russia
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2019年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P10.17D
引用
收藏
页码：1480 / 1480
页数：1
相关论文
共 50 条
  • [1] Genetic spectrum of sarcoglycanopathies in a cohort of Russian patients
    Bulakh, Maria
    Polyakova, Daria
    Dadali, Elena
    Rudenskaya, Galina
    Sharkova, Inna
    Markova, Tatiana
    Murtazina, Aysylu
    Demina, Nina
    Kurbatov, Sergei
    Nikitina, Natalia
    Udalova, Vasilisa
    Polyakov, Aleksander
    Ryzhkova, Oxana
    GENE, 2024, 927
  • [2] LGMD2E is the most common type of sarcoglycanopathies in the Iranian population
    Alavi, Afagh
    Esmaeili, Sara
    Nilipour, Yalda
    Nafissi, Shahriar
    Tonekaboni, Seyed Hasan
    Zamani, Gholamreza
    Ashrafi, Mahmoud Reza
    Kahrizi, Kimia
    Najmabadi, Hossein
    Jazayeri, Fatemeh
    JOURNAL OF NEUROGENETICS, 2017, 31 (03) : 161 - 169
  • [3] Sarcoglycanopathies: A multiplex molecular analysis for the most common mutations
    Gouveia, Telma L. F.
    Paim, Julia F. O.
    Pavanello, Rita C.
    Zatz, Mayana
    Vainzof, Mariz
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2006, 15 (02) : 95 - 100
  • [4] Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients
    Hermanová, M
    Zapletalová, E
    Sedlácková, J
    Chrobáková, T
    Letocha, O
    Kroupová, I
    Zámecník, J
    Vondrácek, P
    Mazanec, R
    Maríková, T
    Vohánka, S
    Fajkusová, L
    MUSCLE & NERVE, 2006, 33 (03) : 424 - 432
  • [5] Molecular genetic testing of the sarcoglycanopathies
    Routledge, D.
    Hudson, J. A.
    Curtis, A.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 818 - 818
  • [6] Molecular analysis of sarcoglycan genes in LGMD patients recruited using different methods
    Aurino, S
    Saccone, V
    Piluso, G
    Esposito, M
    Ventriglia, VM
    Trimarco, A
    Politano, L
    Topaloglu, H
    Minetti, C
    Nigro, V
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 719 - 719
  • [7] Analysis of histopathologic and molecular genetic findings in Czech LGMD2A patients
    Hermanova, M
    Fajkusova, L
    Zapletalova, E
    Sedlackova, J
    Vondracek, P
    Zamecnik, J
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 690 - 690
  • [8] Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects
    Sandona, Dorianna
    Betto, Romeo
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2009, 11
  • [9] Mutation analysis of sarcoglycanopathies patients in Saudi Arabia: A pilot study
    Al Jumah, Mohammed A.
    Al Abdulkareem, Ibrahim
    Rehana, Zehra
    NEUROLOGY, 2008, 70 (11) : A311 - A311
  • [10] Molecular analysis of myotilin, the gene responsible for LGMD1A.
    Hauser, MA
    Salmikangas, P
    Torian, UM
    Dancel, R
    Anderson, LVB
    Taivainen, U
    Stajich, JM
    Gaskell, PC
    Vance, JM
    Pericak-Vance, MA
    Carpen, O
    Speer, MC
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 390 - 390
12345